LDL Level Profile Among Prolanis Patients with Hypertension at the UPTD Regional Health Laboratory of Serang City

Hypertension remains a major non-communicable disease and an important public health concern because it increases the risk of cardiovascular complications. Low-density lipoprotein (LDL) plays a central role in atherosclerosis; therefore, monitoring LDL levels is relevant in patients with hypertension, including participants in Indonesia’s Chronic Disease Management Program (Prolanis). This study aimed to describe the LDL level profile among Prolanis patients with hypertension at the UPTD Regional Health Laboratory of Serang City. A quantitative descriptive design with a retrospective approach was used. Secondary data were obtained from laboratory examination results and patient records. The study included 60 patients with hypertension who underwent LDL testing in June 2026. LDL levels were measured using a Mindray BS-230 Chemistry Analyzer, and respondents were selected through purposive sampling. Data were analyzed descriptively according to LDL category, sex, and age group. Near Optimal and Borderline High were the most frequent LDL categories, each comprising 15 respondents (25.0%). High LDL was found in 13 respondents (21.7%), Very High in 9 (15.0%), and Optimal in 8 (13.3%). Overall, 37 respondents (61.7%) had LDL levels ranging from Borderline High to Very High. Most respondents were female (95.0%), and the largest age group was 41–55 years (48.3%), followed by 56–70 years (40.0%). These findings indicate that elevated LDL levels remain common among the studied patients, highlighting the importance of regular lipid-profile monitoring and healthy-lifestyle education. components of early detection and cardiovascular complication prevention in this population.